ARCHIVES

NSABP’s Pink Sheet; Fisher’s Control Had A Downside, Review Said

This article is from The Cancer Letter archive.

Vol. 20 No. 25 | June 24, 1994

Download PDF Visit The Full Archive

Related Articles

Oncology Societies, Cancer Center, List Reform Principles

August 12, 1994

FDA Approves Generic Capecitabine

September 20, 2013

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

December 26, 2008

In Brief: Diane Fink Moves to ACS California Div.; Preisler Names Director Of Cancer Center In Cincinnati

February 10, 1989

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013